Abstract
DHPLC (denaturing high-performance liquid chromatography) has established itself as one of the most powerful tools for DNA variation screening and allele discrimination for the characteristics of sensitivity, accuracy and efficiency that allow a rapid detection of SNPs, insertions and deletions. Moreover, it has the advantages of fullautomation and cost effectiveness. Aside from its well-known application in identifying mutations in human diseases, it has been also implemented in the quantitative measurement of gene expression and the analysis of single nucleotide extension products. In this paper, we aimed at summarizing the general properties and the main applications of DHPLC in the biomedical field as well as comparing this newly developed biotechnology with other conventional pre-screening methods for mutation scanning, such as single strand conformational polymorphisms (SSCP), conformation sensitive gel electrophoresis (CSGE) and two dimensional gene scanning (TDGS).
Keywords: DHPLC, Genetic analysis, Methylated DNA, Mitochondrial DNA, Bacterial DNA
Current Pharmaceutical Analysis
Title: Ion-Pair Reversed-Phase Denaturing HPLC-Based Biotechnology as a Tool for Genetic Analysis
Volume: 2 Issue: 3
Author(s): Maria Visalli, Isabella Venza, Mario Venza, Teresa Catalano and Diana Teti
Affiliation:
Keywords: DHPLC, Genetic analysis, Methylated DNA, Mitochondrial DNA, Bacterial DNA
Abstract: DHPLC (denaturing high-performance liquid chromatography) has established itself as one of the most powerful tools for DNA variation screening and allele discrimination for the characteristics of sensitivity, accuracy and efficiency that allow a rapid detection of SNPs, insertions and deletions. Moreover, it has the advantages of fullautomation and cost effectiveness. Aside from its well-known application in identifying mutations in human diseases, it has been also implemented in the quantitative measurement of gene expression and the analysis of single nucleotide extension products. In this paper, we aimed at summarizing the general properties and the main applications of DHPLC in the biomedical field as well as comparing this newly developed biotechnology with other conventional pre-screening methods for mutation scanning, such as single strand conformational polymorphisms (SSCP), conformation sensitive gel electrophoresis (CSGE) and two dimensional gene scanning (TDGS).
Export Options
About this article
Cite this article as:
Visalli Maria, Venza Isabella, Venza Mario, Catalano Teresa and Teti Diana, Ion-Pair Reversed-Phase Denaturing HPLC-Based Biotechnology as a Tool for Genetic Analysis, Current Pharmaceutical Analysis 2006; 2 (3) . https://dx.doi.org/10.2174/157341206777934653
DOI https://dx.doi.org/10.2174/157341206777934653 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Von Willebrand Factor and Cardiovascular Disease: From a Biochemical Marker to an Attractive Therapeutic Target
Current Vascular Pharmacology Carnitine Metabolism and Deficit - When Supplementation is Necessary?
Current Pharmaceutical Biotechnology Transient Receptor Potential (TRP) Channels and Cardiac Fibrosis
Current Topics in Medicinal Chemistry The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
Current Neurovascular Research The Evolving Therapy of Rheumatic Diseases, The Future is Now
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Microparticles in Health and Disease: Small Mediators, Large Role?
Current Vascular Pharmacology Proteomic and Bioinformatic Analysis of Trypanosoma cruzi Chemotherapy and Potential Drug Targets: New Pieces for an Old Puzzle
Current Drug Targets The Evolving Roles of Nuclear Cardiology
Current Cardiology Reviews Antioxidant Properties of Melatonin and its Potential Action in Diseases
Current Topics in Medicinal Chemistry New Heterocyclic Compounds: Synthesis, Antioxidant Activity and Computational Insights of Nano-Antioxidant as Ascorbate Peroxidase Inhibitor by Various Cyclodextrins as Drug Delivery Systems
Current Drug Delivery Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations
Current Pharmaceutical Design Editorial [ Hot Topic: Modifying Cardiovascular Risk Factors: Novel Cardiovascular Targets for Treatment by Noninvasive Imaging Techniques (Executive Editors: Aurelio Leone and Luigi Landini) ]
Current Pharmaceutical Design Macrovascular Complications of Type 2 Diabetes Mellitus
Current Vascular Pharmacology Light Chain Amyloidosis – Current Findings and Future Prospects
Current Protein & Peptide Science Patent Selections
Recent Patents on Cardiovascular Drug Discovery Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Current Medicinal Chemistry Levosimendan Reduces Prostaglandin F2a-dependent Vasoconstriction in Physiological Vessels and After Experimentally Induced Subarachnoid Hemorrhage
Current Neurovascular Research Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design The Two Faces of Iminoalditols: Powerful Inhibitors Trigger Glycosidase Activation
Current Enzyme Inhibition